Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

NCT06217302 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Nephropathies
Kidney Failure, Chronic
Diabetes Mellitus Type 1
Heart Failure

Interventions

DRUG: Sotagliflozin
DRUG: Placebo

Sponsor

Alessandro Doria

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]